Project Grant R16AI201136
- Federal Project Grant Award Summary The University of New Mexico received a $430,251 Project Grant from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded June 18, 2025, with a completion date of May 31, 2027. This award supports fine-resolution genetic mapping research utilizing advanced intercross lines of Biomphalaria glabrata, a primary snail vector for Schistosoma mansoni. The project employs double...
- Summary of Federal Project Grant Award The Schistosomiasis Resource Center (SRC) at the Biomedical Research Institute (BRI) received a $1.8M Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period July 1, 2026 through June 30, 2031. The SRC operates as a centralized, cost-efficient production and supply laboratory that provides no-cost schistosomiasis research reagents and...
- Federal Grant Award Summary The University of California, San Diego received a $438,500 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on July 21, 2025, with a completion date of June 30, 2027. This award supports the development of new tools to facilitate drug discovery targeting pathogen proteasomes, which represent an emerging therapeutic target for treating parasitic...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $899,850 to the Whitehead Institute for Biomedical Research on February 20, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports a five-year project (through January 31, 2031) investigating how apicomplexan parasites, such as Toxoplasma and Plasmodium, recognize and invade host cells. The research deliverables include peer-reviewed publications and...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $133,800 to Fundacion Instituto De Investigaciones Biotecnologicas under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 11, 2025, for a project period extending through July 31, 2030. This Project Grant funds biomedical research investigating protein trafficking mechanisms in Trypanosoma cruzi, the parasitic agent responsible for Chagas disease, which...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded University of California, Los Angeles $157,500 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for a Project Grant commencing April 1, 2026 and concluding March 31, 2028. The award supports research on the structure and ligand binding of receptor adenylate cyclase from Trypanosoma brucei, a flagellated eukaryotic pathogen responsible for African trypanosomiasis. The...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $440,000 in Project Grant funding under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Texas Medical Branch at Galveston, effective July 3, 2025, through June 30, 2027. This award supports research to determine the function and mechanism of long non-coding RNA CHAST in Trypanosoma cruzi infection and dissemination, which causes Chagas disease. The...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $148,614 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) on March 23, 2026, with a completion date of December 31, 2028. This fellowship award supports mentored training and research on malaria transmission dynamics in relation to international migration and environmental health factors...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Texas Medical Branch at Galveston a $444,125 Project Grant (CFDA 93.855: Allergy and Infectious Diseases Research) effective June 12, 2026, with a completion date of May 31, 2028. The award funds research investigating the role of long non-coding RNAs (lncRNAs) in modulating host immunity and pathogen survival during Orientia tsutsugamushi infection, which causes scrub...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $451,000 to the University of California, San Francisco under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 15, 2025, with completion scheduled for July 31, 2027. This Project Grant supports the development and application of high-resolution phage immunoprecipitation sequencing (PhIP-Seq) arrays designed to comprehensively evaluate antibody responses to...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Puerto Rico Medical Sciences Campus a Project Grant totaling $149,000 under the Allergy and Infectious Diseases Research program (CFDA 93.855). This award, issued July 10, 2026 and extending through June 30, 2030, funds the SURE (Support for Research Excellence) project entitled "Targeting Snail Reproduction to Block Schistosomiasis Transmission." The research addresses the critical global health challenge of schistosomiasis, which affects over 236 million people in more than 70 countries, by investigating how the Schistosoma mansoni parasite suppresses reproduction in its intermediate host, the Biomphalaria glabrata snail. This understanding could enable development of novel snail-control strategies to reduce disease transmission without eradicating host populations. The project will deliver fundamental research products examining parasitic castration mechanisms through integrated laboratory analyses, including wholemount immunohistochemistry, hybridization chain reaction detection of neuropeptide messenger RNAs, and neurophysiological techniques. Specifically, the investigation focuses on two neuropeptide families—cholecystokinin and gonadotropin-releasing hormone related peptides—implicated in snail reproduction, analyzing their expression patterns across the infection chronology at both messenger RNA and protein levels in identified neurons and reproductive tissues. In addition to scientific outputs, the award provides research training opportunities for undergraduate and graduate students at this Hispanic-serving minority institution located in Puerto Rico, contributing to the development of the biomedical research workforce in infectious disease studies.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $149.0k | 7/14/26 |